Header Logo

Connection

DONALD PARSONS to Cyclin-Dependent Kinase Inhibitor p16

Back to Details
This is a "connection" page, showing publications DONALD PARSONS has written about Cyclin-Dependent Kinase Inhibitor p16.
DONALD PARSONS
Connection Strength
0.036
Cyclin-Dependent Kinase Inhibitor p16
  1. Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group. Clin Cancer Res. 2018 08 15; 24(16):3888-3897.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.